Acromegaly Update on Management and Long-Term Morbidities

被引:14
作者
Kasuki, Leandro [1 ,2 ,3 ,4 ]
Antunes, Ximene [1 ,2 ]
Lamback, Elisa Baranski [1 ,2 ]
Gadelha, Monica R. [1 ,2 ,3 ,5 ]
机构
[1] Univ Fed Rio de Janeiro, Endocrinol Div, Neuroendocrinol Res Ctr, Med Sch, Rua Prof Rodolpho Paulo Rocco 255,9 Andar Setor 9, BR-21941913 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rua Prof Rodolpho Paulo Rocco 255,9 Andar Setor 9, BR-21941913 Rio De Janeiro, Brazil
[3] Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, 156th Resende St, Rio De Janeiro, RJ, Brazil
[4] Hosp Fed Bonsucesso, Endocrinol Div, Rio De Janeiro, Brazil
[5] Inst Estadual Cerebro Paulo Niemeyer, Neuropatol & Mol Genet Lab, Rio De Janeiro, Brazil
关键词
Acromegaly; Somatotropinoma; Pituitary adenoma; Comorbidities; Treatment; GROWTH-FACTOR-I; SOMATOSTATIN ANALOGS; VERTEBRAL FRACTURES; HIGH PREVALENCE; BIOCHEMICAL CONTROL; LOW-FREQUENCY; SLEEP-APNEA; HORMONE; OCTREOTIDE; RADIOTHERAPY;
D O I
10.1016/j.ecl.2020.05.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acromegaly is a systemic disease associated with great morbidity and increased mortality if not adequately treated. In the past decades much improvement has been achieved in its treatment and in the knowledge of its comorbidities. We provide an update of acromegaly management with current recommendations. We also address long-term comorbidities emphasizing the changing face of the disease in more recent series, with a decrease of cardiovascular disease severity and an increased awareness of comorbidities like bone disease, manifested mainly as vertebral fractures and the change in the main cause of death (from cardiovascular disease to cancer in more recent series).
引用
收藏
页码:475 / +
页数:13
相关论文
共 82 条
  • [11] Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis
    Bolfi, F.
    Neves, A. F.
    Boguszewski, C. L.
    Nunes-Nogueira, V. S.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (01) : 59 - 71
  • [12] Increased prevalence of radiological spinal deformities in active acromegaly: A cross-sectional study in postmenopausal women
    Bonadonna, S
    Mazziotti, G
    Nuzzo, M
    Bianchi, A
    Fusco, A
    De Marinis, L
    Giustina, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (10) : 1837 - 1844
  • [13] The incidence of cerebrovascular accidents in patients with pituitary adenoma
    Brada, M
    Burchell, L
    Ashley, S
    Traish, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (03): : 693 - 698
  • [14] Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
    Buchfelder, Michael
    van der Lely, Aart-Jan
    Biller, Beverly M. K.
    Webb, Susan M.
    Brue, Thierry
    Strasburger, Christian J.
    Ghigo, Ezio
    Camacho-Hubners, Cecilia
    Pang, Kaijie
    Lavenbergt, Joanne
    Jonsson, Peter
    Hey-Hadavi, Juliana H.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (06) : 419 - 427
  • [15] Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naive patients with acromegaly: data from the PRIMARYS study
    Caron, Philippe J.
    Petersenn, Stephan
    Houchard, Aude
    Sert, Caroline
    Bevan, John S.
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 (04) : 541 - 551
  • [16] Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
    Casanueva, Felipe F.
    Barkan, Ariel L.
    Buchfelder, Michael
    Klibanski, Anne
    Laws, Edward R.
    Loeffler, Jay S.
    Melmed, Shlomo
    Mortini, Pietro
    Wass, John
    Giustina, Andrea
    [J]. PITUITARY, 2017, 20 (05) : 489 - 498
  • [17] Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal Study
    Chiloiro, Sabrina
    Bima, Chiara
    Tartaglione, Tommaso
    Giampietro, Antonella
    Gessi, Marco
    Lauretti, Liverana
    Anile, Carmelo
    Colosimo, Cesare
    Rindi, Guido
    Pontecorvi, Alfredo
    De Marinis, Laura
    Bianchi, Antonio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (11) : 5478 - 5482
  • [18] Progression of Vertebral Fractures Despite Long-Term Biochemical Control of Acromegaly: A Prospective Follow-up Study
    Claessen, K. M. J. A.
    Kroon, H. M.
    Pereira, A. M.
    Appelman-Dijkstra, N. M.
    Verstegen, M. J.
    Kloppenburg, M.
    Hamdy, N. A. T.
    Biermasz, N. R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12) : 4808 - 4815
  • [19] Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
    Colao, A.
    Bronstein, M. D.
    Freda, P.
    Gu, F.
    Shen, C. -C.
    Gadelha, M.
    Fleseriu, M.
    van der Lely, A. J.
    Farrall, A. J.
    Resendiz, K. Hermosillo
    Ruffin, M.
    Chen, Y.
    Sheppard, M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (03) : 791 - 799
  • [20] Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
    Colao, A
    Ferone, D
    Marzullo, P
    Lombardi, G
    [J]. ENDOCRINE REVIEWS, 2004, 25 (01) : 102 - 152